Should Renin-Angiotensin System Blockade Be Avoided in Patients With Declining Kidney Function?

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: mweir@som.umaryland.edu.
² Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
³ Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA; Division of Nephrology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.

Editorial

Matthew R Weir et al. Am J Kidney Dis. 2020 Nov.

. 2020 Nov;76(5):739-741.

doi: 10.1053/j.ajkd.2020.04.003. Epub 2020 May 12.

¹ Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: mweir@som.umaryland.edu.
² Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
³ Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA; Division of Nephrology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.

No abstract available

Comment on

Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
Qiao Y, Shin JI, Chen TK, Inker LA, Coresh J, Alexander GC, Jackson JW, Chang AR, Grams ME. Qiao Y, et al. JAMA Intern Med. 2020 May 1;180(5):718-726. doi: 10.1001/jamainternmed.2020.0193. JAMA Intern Med. 2020. PMID: 32150237 Free PMC article.